Histogen Obtains New Financing

  • Feed Type
  • Date
    8/11/2015
  • Company Name
    Histogen
  • Mailing Address
    10655 Sorrento Valley Road San Diego, CA 92121 USA
  • Company Description
    Histogen, launched in 2007, seeks to redefine regenerative medicine by developing a series of high value products without the use of embryonic stem cells or animal products. Histogen has two product families – Exceltrix, Histogen’s human Extracellular Matrix (ECM) and HGEN-001, Histogen’s proprietary liquid formula.
  • Website
    http://www.histogeninc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy